Orphan Drugs & Rare Diseases 2019 Americas – West Coast will provide a unique platform for the convergence of stakeholders in the orphan drugs industry to discuss and network with top tier government, hospitals, pharmaceuticals, biopharmaceuticals, non-profit organizations, orphan drugs developers as well as regional and local manufacturers. We are putting together an agenda that address the driving macroeconomic factors, policies and issues that will steer the
development of orphan drugs globally including commercialization, policies, reimbursement, pricing and more.

2019 Speakers

Previous Conference Gallery

Paradigm Global Events

ADD THIS EVENT TO YOUR CALENDAR

22 - 24 Jul 2019

Windows   Apple   Google

Who Attends

Orphan Drugs & Rare Diseases congress provides a unique platform for the convergence of stakeholders in the orphan drugs industry to discuss and network with top tier government, hospitals, pharmaceuticals, biopharmaceuticals, non-profit organizations, orphan drugs developers as well as regional and local manufacturers.

 

AbbVie – Access Matters – Actelion – Agility Clinical Inc – Albireo Pharma – Alexion Pharma GmbH – Alexion Pharmaceuticals, Inc. – Alnylam – Amicus Therapeutics – Armetheon Inc – Barrington James – Bay City Capital – BenevolentAI – Biogen – Biogen Idec Japan – Biomedical Systems – BioPontis Alliance for Rare Diseases – BluePrint Orphan – Stratis Group – Boehringer Ingelheim – Bridge Consulting – BridgeBio – Cambridge Rare Diseases Network – Celgene – CentogeneheckOrphan – Chiesi Farmaceutici S.p.A – Clincierge – Codenix – Complete HealthVizion – Cote Orphan – Covance Laboratories – CRF Health – Cymabay Therapeutics – Cytel – DefiniGEN Ltd – DNAlight Therapeutics – Dolon Ltd – Dravet Syndrome – Foundation Europe – Drug Committee of the German Medical Association (AKDÄ) – Eiger BioPharmaceuticals – EMD Serono, Inc – Enable Biosciences Inc – Evotec (UK) – F. Hoffmann – La Roche Ltd – Facio Therapies – GB Pharma Services & Consulting Srl – Genentech / Codon Capital – Genetic – Global Service Pharmaceuticals SAS – GlobalData – Glycomine Inc. – GMAx Consulting LLC – GSK – Guthy Jackson Foundation – GW Pharmaceuticals – Houston Methodist Research Institute – HSGBU Oracle UK – INC Research/inVentiv Health – IndieBio – INSERM – Jain Foundation – LYSOGENE – Manson Associates – MAPI Group – MC Business Consulting – MEDExpansion – Medical Marketing Economics – Medicopharma Solutions – Medpace – Merck – Mereo BioPharma – Mission Bay Capital – Mitsubishi Tanabe Pharma Europe Ltd – Myokardia, Inc. – MytoDys Therapeutics – National Alliance of People with Rare Diseases – Novartis – NYSE – ONXEO – Opsona Therapeutics – Optum – Oracle – Orphan Drugs Industry Advisory & Intelligence – Palo Alto Investors – Pfizer – Premier Research – PSR Group B.V. – Pulse InfoFrame – Qiagen – Rare Disease Report – Rare Genomics Institute – Rarebase – Raremark – Recursion Pharmaceuticals – REGENXBIO – Rho Inc. – Roche – Root Lines Technology – Royal Holloway, University of London – S3 Connected Health – Sanofi Genzyme – Sanofi Pasteur MSD – Savara Pharmaceuticals – Seeker Health – Shire – Simbec Orion – Siolta Therapeutics – Stanford University – SyntheX, Inc – TB – SEQ Inc. – The Planning Shop International – The Scripps Translational Science Institute – UCSF Helen Diller Family Comprehensive Cancer Center – Venn Life Sciences – Vertex – Vifor Pharma – Xenon Pharmaceuticals Inc.

LOOKING FORWARD TO MEETING YOU IN SAN FRANCISCO!

To Sponsor/Exhibit

To Speak

To Register

sponsor@paradigmglobalevents.com
Tel. +44 203 567 1321

jocelynr@paradigmglobalevents.com
Tel. +44 203 567 1321

booking@paradigmglobalevents.com
Tel. +44 203 567 1321